Puma Biotechnology Inc (PBYI) — Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

Puma Biotechnology Inc (PBYI) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $14.46 Million represents 1% of operating cash flow ($14.42 Million). Read PBYI total debt and obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$14.46 Million
USD

Operating Cash Flow

$14.42 Million
USD

Capital Expenditures

$36.00K
USD

Puma Biotechnology Inc Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for Puma Biotechnology Inc across 6 annual periods. Explore PBYI capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Puma Biotechnology Inc (2019–2025)

Year-by-year Free Cash Flow Generation Index for Puma Biotechnology Inc. For the full company profile including market capitalisation, see PBYI market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $41.73 Million $41.80 Million $71.00K ▼ 0.0%
2024 1.00x $38.86 Million $38.92 Million $56.00K ▲ +87.7%
2023 0.53x $14.37 Million $27.01 Million $12.64 Million ▼ -46.8%
2021 1.00x $20.65 Million $20.65 Million $1.00K ▲ +104.2%
2020 -24.06x $-19.25 Million $800.00K $20.05 Million ▼ -2539.1%
2019 0.99x $22.07 Million $22.38 Million $306.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).